EUVIMED · CrossrefZeitschrift
CNS Drug Reviews
ISSN 1080-563X · Wiley
Neueste Artikel
Nitroparacetamol (NCX‐701) and Pain: First in a Series of Novel Analgesics
Catechol‐ O ‐methyltransferase and Its Inhibitors in Parkinson's Disease
A New Look at the Respiratory Stimulant Doxapram
Pharmacological Profile of the Selective FAAH Inhibitor KDS-4103 (URB597)
Pharmacological Properties, Central Nervous System Effects, and Potential Therapeutic Applications of Atipamezole, a Selective α 2 ‐Adrenoceptor Antagonist
Piracetam: A Review of Pharmacological Properties and Clinical Uses
The Neuropharmacological Basis for the Use of Memantine in the Treatment of Alzheimer's Disease
Xanomeline and the Antipsychotic Potential of Muscarinic Receptor Subtype Selective Agonists
A Review of the Properties of Spiradoline: A Potent and Selective k‐Opioid Receptor Agonist
BMS‐204352: A Potassium Channel Opener Developed for the Treatment of Stroke
Almotriptan, a New Anti‐Migraine Agent: A Review
Galantamine — a Novel Cholinergic Drug with a Unique Dual Mode of Action for the Treatment of Patients with Alzheimer's Disease
Phenibut (β‐Phenyl‐GABA): A Tranquilizer and Nootropic Drug
Fluvoxamine as an Adjunctive Agent in Schizophrenia
The Selective Serotonin Reuptake Inhibitor Sertraline: Its Profile and Use in Psychiatric Disorders
Paroxetine: A Review
R ‐2HMP: an Orally Active Agent Combining Independent Antiapoptotic and MAO‐B‐Inhibitory Activities
Vigabatrin
The Pharmacology of Physostigmine
Preclinical Pharmacology of ABT‐418: A Prototypical Cholinergic Channel Activator for the Potential Treatment of Alzheimer's Disease
CI‐1002: A Combined Acetylcholinesterase Inhibitor and Muscarinic Antagonist 1
ICI 204,636 (SEROQUEL™): A Dibenzothiazepine Atypical Antipsychotic. Review of Preclinical Pharmacology and Highlights of Phase II Clinical Trials
Modulation of the NMDA Receptor Complex by D‐Cycloserine
Neuroprotective Action of Nicardipine Hydrochloride
Evaluation of Cognition‐enhancing Drugs: Utility of the Model System of Eyeblink Classical Conditioning
The Pharmacology of GYKI‐46 903, a New Cognition Enhancer
Lifarizine: A Blocker of Inactivated Voltage‐dependent Sodium Channels and Calcium Channels with Cerebral Neuroprotective Action
Imidazenil: A Potent Benzodiazepine Partial Positive Modulator of GABAergic Transmission Virtually Devoid of Tolerance Liability
Lamotrigine
Lomerizine (KB‐2796), a New Antimigraine Drug
EUVIMED